Speciality Medicines Limited (BOM:544738)
India · Delayed Price · Currency is INR 172.15
0.00 (0.00%)
At close: Oct 6, 2026
Speciality Medicines Revenue
In the fiscal year ending March 31, 2026, Speciality Medicines had annual revenue of 752.85M INR with 29.20% growth. Speciality Medicines had revenue of 82.01M in the quarter ending May 31, 2024. That makes Speciality Medicines the world's 38,352nd largest company by revenue and 3,420th in India.
Revenue
752.85M
Revenue Growth
+29.20%
P/S Ratio
2.01
Revenue / Employee
30.11M
Employees
25
Market Cap
1.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 752.85M | 170.14M | 29.20% |
| Mar 31, 2025 | 582.71M | 307.47M | 111.70% |
| Mar 31, 2024 | 275.25M | 42.84M | 18.43% |
| Mar 31, 2023 | 232.41M | -172.03M | -42.54% |
| Mar 31, 2022 | 404.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 3.34B |
| Parnax Lab | 2.52B |
| Lactose (India) | 1.71B |
| Aayush Wellness | 1.66B |
| Makers Laboratories | 1.49B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| Godavari Drugs | 1.11B |